Global Microfluidics Device Market Research Report 2021

Microfluidics deals with the behaviour, precise control and manipulation of fluids that are geometrically constrained to a small, typically sub-millimeter, scale at which capillary penetration governs mass transport. It is a multidisciplinary field at the intersection of engineering, physics, chemistry, biochemistry, nanotechnology, and biotechnology, with practical applications in the design of systems in which low volumes of fluids are processed to achieve multiplexing, automation, and high-throughput screening.
Advances in microfluidics technology are revolutionizing molecular biology procedures for enzymatic analysis (e.g., glucose and lactate assays), DNA analysis (e.g., polymerase chain reaction and high-throughput sequencing), and proteomics. The basic idea of microfluidic biochips is to integrate assay operations such as detection, as well as sample pre-treatment and sample preparation on one chip.

The global Microfluidics Device market was valued at US$ 5861.3 million in 2019 and is expected to reach US$ 16550 million by the end of 2026, growing at a CAGR of 15.8% during 2021-2026.
This report focuses on Microfluidics Device volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Microfluidics Device market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Microfluidics Device Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Material
Glass
Polymer
Silicon

Segment by Application
Pharmaceutical and Life Science Research
Clinical and Veterinary Diagnostics
Drug Delivery
Environmental and Industrial
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
Roche
Abbott Laboratories
Siemens Healthcare
Agilent Technologies
Fluidigm Corporation
Bio-Rad Laboratories
Cepheid
Dolomite Centre
Micronit Microfluidics
Johnson & Johnson
Becton, Dickinson And Company